Target intelligence / Profile preview

C12orf75 antisense RNA 1 (C12orf75-AS1)

Target
C12orf75-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

C12orf75 antisense RNA 1 (C12orf75-AS1) is a long non-coding RNA found on chromosome 12 (12q23.3), frequently referenced as KCCAT198 and associated with renal cell carcinoma, particularly the clear cell subtype[5]. Like other antisense RNAs, C12orf75-AS1 is presumed to regulate gene expression by hybridizing to sense transcripts, possibly influencing cell migration, invasion, and tumor progression indirectly[11]. While C12orf75-AS1 has been identified as a potential cancer biomarker, no drugs directly target it. Its precise function, mechanisms, and clinical significance are still being elucidated in the context of non-coding RNA research[5][7][8][11]. If you seek structured data for database import, these guidelines will apply. If you need mapping to protein-coding entities, note that C12orf75-AS1 is distinct from C12orf75 (OCC-1, Overexpressed in colon carcinoma-1)[3][5].

Other names
KCCAT198renal clear cell carcinoma-associated transcript 198C12orf75-AS1
02

Mechanism of action

Not applicable for approved drugs. In principle, antisense RNA molecules act by hybridizing to complementary mRNA, interfering with translation or mRNA stability—an approach used in research and sometimes in therapeutic oligonucleotide development.

03

Biological functions

Gene expression regulationEpigenetic modulationMay play roles in cell migration and invasion, as inferred from studies on related protein-coding gene C12orf75
04

Disease associations

Cancer (notably renal cell carcinoma)Potential biomarker for renal clear cell carcinoma and possibly other tumors
05

Safety considerations

No data. Safety concerns with targeting antisense RNAs generally include specificity and off-target effects
06

Interacting drugs

None known
07

Biomarkers

Potential biomarker for renal cell carcinoma prognosis and diagnosis, especially clear cell subtype

Beyond the preview

Go deeper on C12orf75 antisense RNA 1 (C12orf75-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C12orf75 antisense RNA 1 (C12orf75-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call